| Revision as of 00:44, 31 July 2011 editArcadian (talk | contribs)163,050 edits removed Category:Cancer treatments; added Category:Monoclonal antibodies for tumors using HotCat← Previous edit |
Latest revision as of 00:54, 14 May 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,831 edits Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound"Tag: Shortdesc helper |
| (16 intermediate revisions by 12 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Monoclonal antibody}} |
|
{{drugbox |
|
|
|
{{Drugbox |
| ⚫ |
| verifiedrevid = 400278929 |
|
|
|
| Verifiedfields = changed |
| ⚫ |
| type = mab |
|
|
⚫ |
| verifiedrevid = 458275734 |
|
| image = |
|
| image = |
| ⚫ |
| mab_type = mab |
|
|
|
<!-- Monoclonal antibody data --> |
| ⚫ |
| source = o |
|
|
⚫ |
| type = mab |
| ⚫ |
| target = B-lymphoma cell |
|
|
⚫ |
| mab_type = mab |
| ⚫ |
| CAS_number = 145832-33-3 |
|
|
⚫ |
| source = o |
| ⚫ |
| ATC_prefix = none |
|
|
⚫ |
| target = B-lymphoma cell |
| ⚫ |
| ATC_suffix = |
|
|
|
<!-- Clinical data --> |
| ⚫ |
| PubChem = |
|
|
| DrugBank = |
|
| tradename = |
|
| chemical_formula = |
|
| pregnancy_AU = |
|
| molecular_weight = |
|
| pregnancy_US = |
|
| bioavailability = |
|
| pregnancy_category = |
|
| protein_bound = |
|
| legal_AU = |
|
| metabolism = |
|
| legal_CA = |
|
⚫ |
| legal_UK = |
|
⚫ |
| legal_US = |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
<!-- Pharmacokinetic data --> |
|
|
| bioavailability = |
|
|
| protein_bound = |
|
|
| metabolism = |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
|
<!-- Identifiers --> |
|
| pregnancy_AU = |
|
|
|
| CAS_number_Ref = {{cascite|correct|CAS}} |
|
| pregnancy_US = |
|
|
⚫ |
| CAS_number = 145832-33-3 |
|
| pregnancy_category= |
|
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| legal_AU = |
|
|
|
| UNII = 8Z3Q8X4UAD |
|
| legal_CA = |
|
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ⚫ |
| legal_UK = |
|
|
|
| ChemSpiderID = none |
| ⚫ |
| legal_US = |
|
|
⚫ |
| ATC_prefix = none |
| ⚫ |
| legal_status = |
|
|
⚫ |
| ATC_suffix = |
| ⚫ |
| routes_of_administration = |
|
|
⚫ |
| PubChem = |
|
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
|
| DrugBank = |
|
|
<!-- Chemical data --> |
|
|
| chemical_formula = |
|
|
| molecular_weight = |
|
}} |
|
}} |
|
|
|
|
|
|
'''Detumomab''' is a ] ] targeting human ].<ref>{{cite journal | title = International Nonproprietary Names (INN) for Pharmaceutical Substances. | journal = WHO Drug Information | volume = 7 | issue = 4 | date = 1993 | url = http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list70.pdf | archive-url = https://web.archive.org/web/20070614042528/http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list70.pdf | archive-date = 14 June 2007 }}</ref><ref name="Singh_2018">{{cite journal | vauthors = Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, Chugh VK | title = Monoclonal Antibodies: A Review | journal = Current Clinical Pharmacology | volume = 13 | issue = 2 | pages = 85–99 | date = 2018 | pmid = 28799485 | doi = 10.2174/1574884712666170809124728 | s2cid = 27211386 }}</ref> |
|
'''Detumomab''' is a ] ]<ref></ref> developed for the treatment of cancer.{{Citation needed|date=September 2009}} |
|
|
|
|
|
|
==References== |
|
==References== |
| Line 40: |
Line 54: |
|
|
|
|
|
{{monoclonal-antibody-stub}} |
|
{{monoclonal-antibody-stub}} |
|
|
{{antineoplastic-drug-stub}} |
|
|
|
|
] |
|